Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- Common antibiotic Azithromycin carries cardiovascular death: Study - Newstrack India
- IBNLive
- Zithromax (Azithromycin): FDA Statement on Risk of Cardiovascular Death - Bay Net
- Bay NetZithromax (Azithromycin): FDA Statement on Risk of Cardiovascular DeathBay NetFDA is reviewing the results from this study and will communicate any new information on azithromycin and this study or the potential risk of QT interval prolongation after the agency has completed its review
- FDA to Review CV Risk With Azithromycin - Medscape
- FDA to Review CV Risk With AzithromycinMedscapeMay 17, 2012 — The US Food and Drug Administration (FDA) will review a new study showing that patients taking azithromycin (Zithromax, Pfizer) face a small increased risk for sudden cardiac death compared with patients taking amoxicillin
- Zithromax, Widely Used Antibiotic Known As Z-Pak, Linked With Rare But Deadly ... - Huffington Post
- CBC
- Bernstein Liebhard LLP Investigating Potential Lawsuits On Behalf Of Victims ... - San Francisco Chronicle (press release)
- Bernstein Liebhard LLP Investigating Potential Lawsuits On Behalf Of Victims
